CVRx to Present at the Piper Sandler 36th Annual Healthcare Conference
20 nov. 2024 16h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 20, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Piper...
CVRx Announces Positive Outpatient Payment for Barostim Procedure in 2025
04 nov. 2024 08h00 HE
|
CVRx, Inc.
MINNEAPOLIS, Nov. 04, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the Centers for Medicare and Medicaid Services...
CVRx Reports Third Quarter 2024 Financial and Operating Results
29 oct. 2024 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, Oct. 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...
CVRx announces new CPT® Category I codes for Barostim
18 oct. 2024 14h08 HE
|
CVRx, Inc.
MINNEAPOLIS, Oct. 18, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that the American Medical Association (AMA) CPT®...
CVRx to Report Third Quarter 2024 Financial and Operating Results and Host Conference Call on October 29, 2024
15 oct. 2024 16h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Oct. 15, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing Barostim™, an...
CVRx announces new publication reinforcing the long-term quality of life benefits of Barostim
12 sept. 2024 08h00 HE
|
CVRx, Inc.
New data published in JACC: Heart Failure demonstrate durable benefits in MLWHF and EQ-5D quality of life measures in heart failure patients with reduced ejection fraction MINNEAPOLIS, Sept. 12,...
CVRx Announces Appointment of Two New Board Members
03 sept. 2024 08h30 HE
|
CVRx, Inc.
MINNEAPOLIS, Sept. 03, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced the appointments of Kevin Ballinger and Mitch Hill to...
CVRx Announces Increased Inpatient Payment for Barostim Procedure
02 août 2024 08h00 HE
|
CVRx, Inc.
MINNEAPOLIS, Aug. 02, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company, announced today that Centers for Medicare and Medicaid Services (CMS)...
CVRx to Present at the Canaccord Genuity 44th Annual Growth Conference
31 juil. 2024 16h27 HE
|
CVRx, Inc.
MINNEAPOLIS, July 31, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) ("CVRx"), a commercial-stage medical device company, today announced that the management team will present at the Canaccord...
CVRx Reports Second Quarter 2024 Financial and Operating Results
29 juil. 2024 16h05 HE
|
CVRx, Inc.
MINNEAPOLIS, July 29, 2024 (GLOBE NEWSWIRE) -- CVRx, Inc. (NASDAQ: CVRX) (“CVRx”), a commercial-stage medical device company focused on developing, manufacturing and commercializing innovative...